Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MannKind
MannKind
Mannkind and BioMimetic Suffer From Poor Management
Seeking Alpha
Tue, 07/19/11 - 12:13 pm
MannKind
BioMimetic Therapeutics
Mannkind and BioMimetic Suffer From Poor Management
Tue, 07/19/11 - 11:53 am
MannKind
BioMimetic Therapeutics
Augment Bone Graft
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
MannKind
Celgene
Amarin
Vertex Pharmaceuticals
BioSante
Keryx
Amylin
Regeneron
Immunogen
Cubist Pharmaceuticals
Isis Pharmaceuticals
Sunesis
OPKO Health
SciClone
Cephalon
Should Biotech Investors Go Where Institutions Won't?
Investopedia
Thu, 07/7/11 - 12:04 pm
investors
biotech
Aeterna Zentaris
YM BioSciences
Ziopharm
Oncothyreon
Seattle Genetics
Exelixis
MannKind
MELA Sciences
Neoprobe
Zalicus
Studies Show No Increased Risk of Cardiac Events in Diabetes Patients Treated with Afrezza
Yahoo/BusinessWire
Sat, 06/25/11 - 10:39 am
Afrezza
MannKind
insulin
diabetes
10 Undervalued Biotech Stocks With Insider Buying
Seeking Alpha
Thu, 06/23/11 - 09:01 am
Chelsea Therapeutics
Corcept Therapeutics
Complete Genomics
Indenix
EXACT Sciences
QLT
MannKind
Theravance
Regeneron
Ziopharm
8 Potential Biotech Acquisition Candidates
Seeking Alpha
Mon, 06/20/11 - 09:30 am
biotech
M&A
Arena Pharmaceuticals
Biomarin
Dendreon
Human Genome Sciences
Keryx
MannKind
Novartis
Orexigen
Vivus
As the Market Dips, It's Time to Look for Biotech Sector Deals
Seeking Alpha
Sun, 06/12/11 - 10:45 am
Amarin
Dendreon
Titan
Avanir
Celldex
CytRx
MannKind
MannKind: How Much Longer Should It Wait for FDA Approval?
Seeking Alpha
Thu, 05/19/11 - 01:57 pm
MannKind
FDA
inhaled insulin
Afrezza
diabetes
MannKind Evenly Poised
Yahoo/Zacks
Sat, 05/14/11 - 12:31 pm
MannKind
Waiting for MannKind's Pot of Gold
Motley Fool
Wed, 05/11/11 - 08:45 am
MannKind
inhaled insulin
diabetes
MannKind: Afrezza Delayed Again
TheStreet.com
Tue, 05/10/11 - 10:28 am
MannKind
Afrezza
inhaled insulin
diabetes
Mankind Earnings: Looking for a Rebound
Seeking Alpha
Mon, 05/9/11 - 10:56 am
earnings
MannKind
Biotech Calendar: Key Dates for May
Seeking Alpha
Mon, 05/2/11 - 12:42 pm
biotech
Columbia Laboratories
KV Pharmaceutical
Dendreon
Vertex Pharmaceuticals
MannKind
Alimera
Merck
NPS Pharmaceuticals
Ironwood
BioMimetic Therapeutics
Lexicon Pharmaceuticals
Avanir
Optimer
JNJ
Insider Picks: 5 Biotech Stocks Being Snapped Up by Insider Executives
Seeking Alpha
Wed, 04/27/11 - 11:46 am
Complete Genomics
Corcept Therapeutics
Seattle Genetics
Ziopharm
MannKind
Mannkind Denied Again by FDA; Investors Should Consider Generex
Seeking Alpha
Wed, 04/13/11 - 07:55 am
inhaled insulin
MannKind
FDA
Generex
Afrezza
Yet Another Step Back For MannKind
Pharmalot
Mon, 04/11/11 - 12:40 pm
diabetes
MannKind
inhaled insulin
Afrezza
MannKind Provides Regulatory Update
Yahoo/BusinessWire
Sat, 04/9/11 - 11:05 am
MannKind
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 04/4/11 - 11:06 pm
Gilead Sciences
Exelixis
Amgen
Dendreon
Immunogen
Maxygen
MannKind
PDL Biopharma
Celgene
Geron
Vertex Pharmaceuticals
Arena Pharmaceuticals
Human Genome Sciences
Orexigen
Biogen Idec
Amarin Example Shows Common Sense Is Crucial in Navigating Biotech Sector Volatility
Seeking Alpha
Wed, 03/23/11 - 10:33 am
Amarin
BioDelivery Sciences
Dendreon
Human Genome Sciences
MannKind
Titan
Vanda
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
next ›
last »